Bayer to make 'careful but aggressive' return to pharma M&A, CEO says

Bill Anderson, Bayer CEO (Sean Gallup/Getty Images) May 12, 2026 10:06 AM EDT DealsPharma Bay­er to make 'care­ful but ag­gres­sive' re­turn to phar­ma M&A, CEO says Ayisha Sharma News Reporter Bay­er is back on the mar­ket for drug ac­qui­si­tions af­ter a half-decade on the side­lines, ac­cord­ing to CEO Bill An­der­son. “We’re go­ing to be care­ful … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER